tiprankstipranks
Trending News
More News >
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market

Kairos Pharma, Ltd. (KAPA) Financial Statements

Compare
128 Followers

Kairos Pharma, Ltd. Financial Overview

Kairos Pharma, Ltd.'s market cap is currently $15.17M. The company's EPS TTM is $-0.197; its P/E ratio is -2.56; Kairos Pharma, Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

Kairos Pharma, Ltd. Debt to Assets

Kairos Pharma, Ltd. Cash Flow

Kairos Pharma, Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.